Page last updated: 2024-11-02

phenobarbital and Adenopathy

phenobarbital has been researched along with Adenopathy in 2 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research Excerpts

ExcerptRelevanceReference
"Anamnestic data included a generalised seizure disorder and phenobarbital treatment started one month before presentation."1.48Pseudolymphoma in a cat on phenobarbital treatment. ( Lieser, J; Schwedes, CS, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sohn, SJ1
Jeung, SY1
Chae, HK1
Cho, HS1
An, JH1
Li, Q1
Song, WJ1
Youn, HY1
Lieser, J1
Schwedes, CS1

Other Studies

2 other studies available for phenobarbital and Adenopathy

ArticleYear
Phenobarbital-induced anticonvulsant hypersensitivity syndrome in a cat.
    The Journal of veterinary medical science, 2019, Dec-26, Volume: 81, Issue:12

    Topics: Animals; Anticonvulsants; Cat Diseases; Cats; Drug Hypersensitivity; Epilepsy; Fever; Lymphadenopath

2019
Pseudolymphoma in a cat on phenobarbital treatment.
    The Journal of small animal practice, 2018, Volume: 59, Issue:7

    Topics: Animals; Cat Diseases; Cats; Epilepsy; Female; Lymphadenopathy; Phenobarbital; Pseudolymphoma

2018